Tuberculosis cost-effectiveness of therapy: Difference between revisions
| Line 10: | Line 10: | ||
WHO proposes a defined conceptual framework within which the economic impact of diseases and injuries can be considered and appropriately estimated. <ref name=WHO>{{cite web | title = Cost effectiveness and strategic planning| url = http://www.who.int/choice/economicburden/en/ }}</ref> | WHO proposes a defined conceptual framework within which the economic impact of diseases and injuries can be considered and appropriately estimated. <ref name=WHO>{{cite web | title = Cost effectiveness and strategic planning| url = http://www.who.int/choice/economicburden/en/ }}</ref> | ||
The cost effectiveness in various tubercular control interventions in Africa region is give below. <ref name= | The cost effectiveness in various tubercular control interventions in Africa region is give below. <ref name=Cost>{{cite web | title = Cost effectiveness with TB control interventions| url = http://www.who.int/choice/publications/p_2005_MDG_series_TB.pdf?ua=1}}</ref> | ||
Revision as of 21:15, 24 September 2014
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Tuberculosis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Tuberculosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Cost effectiveness of therapy
While measurements of morbidity and mortality are key considerations for estimating the burden of disease in populations, they provide an incomplete picture of the adverse impact of ill health on human welfare. In particular, the economic consequences of poor health can be substantial.
Analysis of the economic impact of ill-health addresses a number of policy questions concerning the consequences of disease or injury. Some of these questions relate to the microeconomic level of households, firms or government – such as the impact of ill-health on a household’s income or a firm’s profits – while others relate to the macroeconomic level, including the aggregate impact of a disease on a country’s current and future gross domestic product (GDP).
WHO proposes a defined conceptual framework within which the economic impact of diseases and injuries can be considered and appropriately estimated. [1]
The cost effectiveness in various tubercular control interventions in Africa region is give below. [2]
| Intervention | Yearly costs with 95% coverage level |
|---|---|
| Minimal DOTS | 366.3 million $ |
| Full DOTS | 612.2 million $ |
| Minimal DOTS with resistant cases | 495.9 million $ |
| Full combination | 739.4 million $ |